Tisdag 24 Mars | 02:03:48 Europe / Stockholm

Kalender

Est. tid*
2026-08-13 07:00 Kvartalsrapport 2026-Q2
2026-05-13 N/A Årsstämma
2026-02-26 - Bokslutskommuniké 2025
2025-07-31 - Kvartalsrapport 2025-Q2
2025-05-16 - X-dag ordinarie utdelning CRBN 0.64 EUR
2025-05-14 - Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2024-08-08 - Kvartalsrapport 2024-Q2
2024-05-17 - X-dag ordinarie utdelning CRBN 0.61 EUR
2024-05-15 - Årsstämma
2024-05-02 - X-dag bonusutdelning CRBN 0.1
2024-03-01 - Bokslutskommuniké 2023
2023-08-10 - Kvartalsrapport 2023-Q2
2023-05-19 - X-dag ordinarie utdelning CRBN 0.56 EUR
2023-05-17 - Årsstämma
2023-03-03 - Bokslutskommuniké 2022
2022-08-10 - Kvartalsrapport 2022-Q2
2022-07-05 - Extra Bolagsstämma
2022-05-20 - X-dag ordinarie utdelning CRBN 0.56 EUR
2022-05-18 - Årsstämma
2022-02-25 - Bokslutskommuniké 2021
2021-10-27 - Kvartalsrapport 2021-Q3
2021-07-20 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning CRBN 0.56 EUR
2021-05-19 - Årsstämma
2021-04-30 - Kvartalsrapport 2021-Q1
2021-03-05 - Bokslutskommuniké 2020
2020-10-12 - Kvartalsrapport 2020-Q3
2020-07-17 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning CRBN 0.56 EUR
2020-06-29 - Årsstämma
2020-04-30 - Kvartalsrapport 2020-Q1
2020-01-13 - Bokslutskommuniké 2019
2019-11-01 - Kvartalsrapport 2019-Q3
2019-08-07 - Kvartalsrapport 2019-Q2
2019-08-05 - Extra Bolagsstämma
2019-04-26 - Kvartalsrapport 2019-Q1

Beskrivning

LandNederländerna
SektorMaterial
IndustriPlast, kemikalier & fetter
Corbion är verksamt inom livsmedelsindustrin. Bolaget är specialiserat inom utveckling av mjölksyra och emulgeringsmedel. Utöver produceras även mineraler och vitaminer för olika hälsotillskott. En sidoverksamhet återfinn i utveckling av biobaserade kemikalier för hantering av biomaterial, plast och restprodukter. Verksamhet innehas på global nivå, med störst affärsverksamhet inom den europeiska marknaden.

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-02-26 07:00:00

Corbion, the Amsterdam-listed sustainable food-ingredients company that champions preservation through application of science, today publishes its results for the year ending 31 December 2025.

Key highlights annual results 2025: 
  •  Organic sales growth: +2.2%
 (Q4: +5.4%)
    •  Volume/mix: +3.4%
 (Q4: +8.8%)
    •  Price:           -1.2%
 (Q4: -3.4%)
  •  Sales: € 1,267.4 million
 (Q4: € 310.2 million)
  •  Adjusted EBITDA: € 204.3 million  
 (Q4: € 48.0 million)
  • Adjusted EBITDA organic growth of +26.7%
 
  •  Operating profit: € 116.5 million, an organic increase of +66.1%
 
  •  Cash flow from operating activities: € 160.9 million
 
  •  Free Cash Flow: € 90.8 million
 
  •  EPS increased +63.3% to €1.29
 
  • Proposal to distribute a dividend of €1.00 per share consisting of a regular dividend of € 0.64 per share and a special dividend of € 0.36 per share
 


Outlook FY 2026:
  •  Organic sales growth: +3-6%
  •  Adjusted EBITDA margin: ~17%
  •  Free Cash Flow: ~€ 85-90 million


 

€ million*
FY
2025
FY
2024
FY growthFY
Organic growth
 Q4 2025Q4 2024Q4 growthQ4
Organic growth
Sales1,267.41,288.1-1.6%+2.2% 310.2315.2-1.6%+5.4%
Adjusted EBITDA204.3175.0+16.7%+26.7% 48.039.3+22.1%+39.9%
Adjusted EBITDA margin (%)16.1%13.6%   15.5%12.5%  
Operating profit116.577.3+50.7%+66.1% 25.115.2+65.1 %+92.8%

*Continued operations

Commenting on today’s results, Olivier Rigaud, CEO, stated: “I am pleased to announce a strong set of results and recognize the excellent delivery of our teams. In 2025, we met our ambitious growth targets for sales and organic Adjusted EBITDA, and again exceeded our Free Cash Flow goal.

We are proposing to distribute a dividend of € 1.00 per share comprising a regular dividend of € 0.64 per share and a special dividend of € 0.36 per share, underscoring our commitment to consistent shareholder returns.

In Functional Ingredients & Solutions, full-year positive volume/mix drove sales growth, supported by momentum in natural preservation and shelf-life extension. I am proud that our teams lifted Adjusted EBITDA margins by +230 bps through cost and complexity reductions and by developing specialty products in faster-growing natural and label-friendly applications.

Health & Nutrition also delivered strong full-year results, with high-single-digit percent volume/mix growth in the segment overall with all three businesses contributing. Q4 saw particularly strong volume/mix growth (+40%). Pricing declined due to temporarily lower fish oil prices and greater exposure to short-term contracts in aquaculture. The segment delivered solid sales growth and a Q4 adjusted EBITDA margin of ~30% and full-year Adjusted EBITDA margin of 32.5%, supported by high-margin solutions and continued portfolio expansion—demonstrating the value of our products and the resilience of our business model.

Following the announcement at the Capital Markets Day in November 2025, we have started to execute a plan to sell our interest in the TotalEnergies Corbion joint venture.”